Valuation: Aptahem AB

Chart: Aptahem AB

02/10	Aptahem continues work toward patient study with Apta-1	FW
28/09	Aptahem - CEO Mikael Lindstam on the company and upcoming share issue	FW
26/09	Aptahem enters letter of intent for collaboration with professor	FW
18/09	Aptahem trades today on Spotlight excluding unit rights in rights issue	FW
14/09	Aptahem carries out a rights issue, raising SEK 15.6m	FW
31/08	Aptahem steps up partnering work around Apta-1	FW
27/08	Aptahem AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
27/08	Aptahem reports, as expected, unchanged results, CEO: working to move Apta-1 forward	FW
25/08	Aptahem, Jarlen Capital Sign Asset Outlicensing, Commercial Partnership Deal	MT
25/08	Aptahem signs partnership agreement with Jarlen Capital	FW
17/06	Aptahem Improves Quality And Manufacturing Efficiency In A New Apta-1 Test Batch	CI
17/06	Aptahem Reports Improved Production of Apta-1	FW
29/05	Aptahem AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

19/09/25

25/08	Aptahem: Aptahem enters commercial partnership agreement with Jarlen Capital for outlicensing	PU
25/08	Aptahem enters commercial partnership agreement with Jarlen Capital for outlicensing	AQ
22/06	Aptahem: Newsletter June 2026	PU
22/06	Newsletter June 2026	AQ
17/06	Aptahem: Aptahem Improves Quality and Manufacturing Efficiency in a New Apta-1 Test Batch	PU

Manager	Title	Age	Since
Luiza Jedlina CTO	Chief Tech/Sci/R&D Officer	-	01/03/2016
Knut Mikael Ingolf Lindstam CEO	Chief Executive Officer	60	01/01/2014
Ola Skanung DFI	Director of Finance/CFO	62	-

Director	Title	Age	Since
Knut Mikael Ingolf Lindstam BRD	Director/Board Member	60	01/01/2014
Johan Lindh BRD	Director/Board Member	-	-
Ulla Cristina Glad BRD	Director/Board Member	74	01/06/2016

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
APTAHEM AB	+8.39%	-3.06%	-75.85%	-98.40%	902K
WUXI APPTEC CO., LTD.	+4.16%	+3.04%	+49.37%	+94.17%	74.16B
ARGENX SE	-3.11%	-3.53%	+21.92%	+74.60%	57.39B
LONZA GROUP AG	+0.89%	-0.63%	+4.28%	+34.51%	47.64B
REVOLUTION MEDICINES, INC.	+0.36%	+0.81%	+352.17%	+689.61%	44.29B
IQVIA HOLDINGS INC.	-0.96%	-4.50%	+26.36%	+33.18%	42.5B
BEONE MEDICINES AG	-0.20%	-0.77%	+3.74%	+100.60%	40.71B
CELLTRION, INC.	-0.54%	+2.93%	+9.31%	+50.41%	30.97B
WUXI BIOLOGICS (CAYMAN) INC.	-2.68%	+2.92%	+29.63%	+19.50%	28.53B
BIONTECH SE	+0.05%	-1.64%	-7.28%	-14.06%	24.34B
Average	+0.64%	-0.38%	+41.36%	+98.41%	39.05B
Weighted average by Cap.	+0.12%	-0.84%	+58.76%	+129.91%

Aptahem AB is a manufacturer of biological products. The company was founded in 2014 and is located in Malmo, Sweden.

Employees

Sector

Date	Price	Change	Volume
30/09/26	SEK 0.3490	+8.39%	526,344
29/09/26	SEK 0.3220	-8.00%	214,761
28/09/26	SEK 0.3500	-2.78%	528,754
25/09/26	SEK 0.3600	+4.65%	205,741
24/09/26	SEK 0.3440	+9.21%	75,538